Table 1 Clinical data
From: In vivo measurement of stent length by using intravascular ultrasound
Patients (n = 90) | ||
|---|---|---|
Age (years) | 66.6 ± 10.0 | |
Sex (%) | Men | 74 (82.2) |
Women | 16 (17.8) | |
Smokers (%) | 51 (56.7) | |
Hypertension (%) | 60 (66.7) | |
Diabetes mellitus (%) | 32 (35.6) | |
Dyslipidemia (%) | 61 (67.8) | |
Family history (%) | 14 (15.6) | |
Chronic stable angina pectoris (%) | 39 (43.3) | |
Unstable angina pectoris (%) | 29 (32.2) | |
Acute myocardial infarction (%) | 22 (24.4) | |
Ejection fraction | 0.62 ± 0.12 | |
Statin (%) | 52 (57.8) | |
β-Blocker (%) | 27 (30) | |
Calcium antagonist (%) | 39 (43.3) | |
ACE inhibitor (%) | 21 (23.3) | |
ARB (%) | 32 (35.5) | |
Cholesterol, mg/dl | 190.06 ± 35.94 | |
LDL cholesterol, mg/dl | 120.28 ± 28.34 | |
HDL cholesterol, mg/dl | 48.44 ± 13.34 |